Perth – November 01, 2026 -- Orthocell Limited (ASX: OCC) sold 92 units of its Remplir nerve repair wrap in the U.S. in October 2026, generating AU$279,000 in revenue, an 84% increase on the average monthly sales of 50 units in Q1 FY27.

It is the strongest month of U.S. sales since the product launched. The company released the figures ahead of its Annual General Meeting on 6 November 2026. Standard quarterly reporting will continue after the meeting.